Nike Inc. Chairman Philip Knight and his wife Penny Knight pledged $500 million to jumpstart a $1 billion cancer research initiative at Oregon Health & Science University.
Oregon Treasurer Ted Wheeler has climbed to the top of Mount Everest, trekked by snowshoe to the North Pole and is embarking on another quest: cutting fees paid to Wall Street banks.
Boston Scientific Corp.’s Watchman device won the backing of U.S. advisers to be used as a treatment to prevent strokes in people with irregular heartbeats.
Bonnie Balch searched online for a back surgeon and found a pitch she called irresistible: Laser Spine Institute LLC promised to ease her pain and have her out the door in a few hours.
King Pharmaceuticals Inc. and Acura Pharmaceuticals Inc. failed to win a U.S. panel’s backing to sell an experimental painkiller, sending Acura shares down about 45 percent in extended trading.
Women of childbearing age should be screened by their primary doctors to determine if they are victims of domestic abuse, a U.S. panel recommends.
Complex back surgeries in older adults surged 15-fold from 2002 to 2007, driving up medical costs and the risk that patients may develop life-threatening complications, a study found.
Fructose, a sweetener found on many food labels, may contribute to weight gain and obesity because it has minimal effect on brain regions that control appetite, a study by Yale University researchers found.
Boehringer Ingelheim GmbH ’s sexual desire drug flibanserin may not be effective or safe, according to U.S. regulators weighing whether to approve the first pill designed to boost women’s libidos.